Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19
Sonu Abraham, Anju Nohria, Tomas G. Neilan, Aarti Asnani, Anu Mariam Saji, Jui Shah, Tara Lech, Jason Grossman, George M. Abraham, Daniel P. McQuillen, David Martín, Paul E. Sax, Sourbha S. Dani, Sarju Ganatra
Topics & Concepts
MedicineRitonavirDrugAdverse effectDiseasePharmacodynamicsPharmacokineticsPharmacologyCoronavirus disease 2019 (COVID-19)Drug interactionIntensive care medicineInternal medicineVirologyViral loadInfectious disease (medical specialty)VirusAntiretroviral therapyAdenosine and Purinergic SignalingCOVID-19 Clinical Research StudiesPeroxisome Proliferator-Activated Receptors